文献速递冠心病血脂与心血管预防

实时心脏远程康复的效果与成本:随机对照非劣效性试验

Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial.
PubMed 文献 · Heart · 2018-08-27

本研究在冠心病成人中比较远程监测运动心脏康复与中心康复的效果和成本。162名参与者随机接受12周干预,结果显示远程康复在12周最大摄氧量上非劣于中心康复,且项目交付和药物成本更低。

要点

  • 远程心脏康复在12周最大摄氧量上非劣于中心康复。
  • 远程康复参与者24周久坐时间更少,中心康复者12周腰围和臀围更小。
  • 远程康复的项目交付成本和药物成本低于中心康复。

核心结论

  • 远程心脏康复是有效且成本效益好的替代模式,可作为现有服务的补充。

研究设计与样本

  • 随机对照非劣效性试验,纳入162名冠心病成人,随机接受12周远程康复或中心康复。

主要发现

  • 12周最大摄氧量组间校正均数差为0.51(95%CI -0.97至1.98)mL/kg/min,p=0.48,远程康复非劣于中心康复。
  • 24周时远程康复组久坐时间更少,校正均数差为-61.5(95%CI -117.8至-5.3)min/天,p=0.03。
  • 12周时中心康复组腰围更小,校正均数差为1.71(95%CI 0.09至3.34)cm,p=0.04;臀围更小,校正均数差为1.16(95%CI 0.06至2.27)cm,p=0.04。
  • 远程康复组人均项目交付成本为NZD1130/GBP573,中心康复组为NZD3466/GBP1758;药物成本分别为NZD331/GBP168和NZD605/GBP307,p=0.02。
  • 医院服务利用成本组间无统计学显著差异(NZD3459/GBP1754 vs NZD5464/GBP2771,p=0.20)。

临床怎么用

  • 远程心脏康复可作为中心康复的替代或补充,以提高康复可及性和利用率为冠心病患者提供个体化运动处方和实时监测指导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Compare the effects and costs of remotely monitored exercise-based cardiac telerehabilitation (REMOTE-CR) with centre-based programmes (CBexCR) in adults with coronary heart disease (CHD). METHODS: Participants were randomised to receive 12 weeks of telerehabilitation or centre-based rehabilitation. REMOTE-CR provided individualised exercise prescription, real-time exercise monitoring/coaching and theory-based behavioural strategies via a bespoke telerehabilitation platform; CBexCR provided individualised exercise prescription and coaching via established rehabilitation clinics. Outcomes assessed at baseline, 12 and/or 24 weeks included maximal oxygen uptake (V̇O2max, primary) modifiable cardiovascular risk factors, exercise adherence, motivation, health-related quality of life and programme delivery, hospital service utilisation and medication costs. The primary hypothesis was a non-inferior between-group difference in V̇O2max at 12 weeks (inferiority margin=-1.25 mL/kg/min); inferiority margins were not set for secondary outcomes. RESULTS: 162 participants (mean 61±12.7 years, 86% men) were randomised. V̇O2 max was comparable in both groups at 12 weeks and REMOTE-CR was non-inferior to CBexCR (REMOTE-CR-CBexCR adjusted mean difference (AMD)=0.51 (95% CI -0.97 to 1.98) mL/kg/min, p=0.48). REMOTE-CR participants were less sedentary at 24 weeks (AMD=-61.5 (95% CI -117.8 to -5.3) min/day, p=0.03), while CBexCR participants had smaller waist (AMD=1.71 (95% CI 0.09 to 3.34) cm, p=0.04) and hip circumferences (AMD=1.16 (95% CI 0.06 to 2.27) cm, p=0.04) at 12 weeks. No other between-group differences were detected. Per capita programme delivery (NZD1130/GBP573 vs NZD3466/GBP1758) and medication costs (NZD331/GBP168 vs NZD605/GBP307, p=0.02) were lower for REMOTE-CR. Hospital service utilisation costs were not statistically significantly different (NZD3459/GBP1754 vs NZD5464/GBP2771, p=0.20). CONCLUSION: REMOTE-CR is an effective, cost-efficient alternative delivery model that could-as a complement to existing services-improve overall utilisation rates by increasing reach and satisfying unique participant preferences.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Maddison R, Rawstorn JC, Stewart RAH, et al. Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial. Heart. 2018. PMID: 30150328. doi:10.1136/heartjnl-2018-313189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。